{"id":"https://genegraph.clinicalgenome.org/r/3b60b21c-5b0e-49e5-a799-ca487280d022v1.0","type":"EvidenceStrengthAssertion","dc:description":"LMX1A was first reported in relation to autosomal dominant nonsyndromic deafness in 2018 (Wesdorp et al., PMID: 29754270). In affected probands, the degree of hearing loss ranges from mild to profound, and the age of onset from congenital to middle adulthood. Also, the hearing loss may be symmetrical or asymmetrical. 12 variants (missense, nonsense, frameshift) that have been reported in at least 26 probands in 7 publications (PMIDs: 29754270, 32840933, 35254497, 35711095, 36140227, 36519758, 38056549) are included in this curation. The mechanism of pathogenicity is reported to be loss-of-function. This gene-disease relationship is also supported by experimental evidence (mouse models; PMIDs: 10693804, 23226461; https://www.jax.org/strain/002624). Three homozygous mutant mouse models show deafness, inner ear structural anomalies, shortened tails, white belly spotting, and atypical behavior. In summary, there is definitive evidence supporting the relationship between LMX1A and autosomal dominant nonsyndromic deafness. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Hearing Loss GCEP on the meeting date 4/16/25 (SOP Version 11).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/3b60b21c-5b0e-49e5-a799-ca487280d022","GCISnapshot":"https://genegraph.clinicalgenome.org/r/163f8708-7d3b-424a-826a-76e37260745c","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/163f8708-7d3b-424a-826a-76e37260745c_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10007","date":"2025-04-24T14:25:46.076Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/163f8708-7d3b-424a-826a-76e37260745c_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10007","date":"2025-04-22T16:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/163f8708-7d3b-424a-826a-76e37260745c_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2f01056c-5e0a-47e8-9410-589d3ec0d2d1","type":"EvidenceLine","dc:description":"Variant was downgraded as it truncates protein in exon 9/9 and is not NMD-associated.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2f01056c-5e0a-47e8-9410-589d3ec0d2d1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36519758","allele":{"id":"https://genegraph.clinicalgenome.org/r/de412fdf-6647-4816-a390-e799a4843136","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_177398.4(LMX1A):c.915dup (p.Val306CysfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2586967648"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/163f8708-7d3b-424a-826a-76e37260745c_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d458c0b0-7d95-44dc-adda-07d1f9a7d2b8_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29754270","rdfs:label":"p.Cys97Ser (4 affected individuals)","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/d458c0b0-7d95-44dc-adda-07d1f9a7d2b8","type":"Family","rdfs:label":"p.Cys97Ser (4 affected individuals)","member":{"id":"https://genegraph.clinicalgenome.org/r/7ea65729-5e78-43df-857a-a09c9e60eed1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29754270","rdfs:label":"p.Cys97Ser","ageType":"AgeAtOnset","ageUnit":"Days","ageValue":0,"allele":{"id":"https://genegraph.clinicalgenome.org/r/f0777627-0fd0-4b43-8cca-b30232034ea1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_177398.4(LMX1A):c.290G>C (p.Cys97Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA343474315"}},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"significantly progressive hearing loss; db threshold was 112 & 113 dB; vertigo episodes with tinnitus lasted for hours ","phenotypes":["obo:HP_0002321","obo:HP_0001730","obo:HP_0000360"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/53ec2fc8-4625-4b4a-a0f9-4eb159f94f4d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29754270","allele":{"id":"https://genegraph.clinicalgenome.org/r/f0777627-0fd0-4b43-8cca-b30232034ea1"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"age of onset ranged from congenital to 35 years old; all three affected children of affected mother had significantly progressive hearing loss; db threshold ranged from 28-113 db; the children each had vertigo episodes during puberty/adulthood ","phenotypePositiveAllelePositive":4,"phenotypes":["obo:HP_0002321","obo:HP_0001730"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/7ea65729-5e78-43df-857a-a09c9e60eed1"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/364076be-d1e4-458e-9554-3ad0b811e35e_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36519758","rdfs:label":"p.Val306Cysfs*32 (6 affected family members)","estimatedLodScore":1.81,"family":{"id":"https://genegraph.clinicalgenome.org/r/364076be-d1e4-458e-9554-3ad0b811e35e","type":"Family","rdfs:label":"p.Val306Cysfs*32 (6 affected family members)","member":{"id":"https://genegraph.clinicalgenome.org/r/560b8ba8-df32-4368-aac9-d7942788bb6b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36519758","rdfs:label":"p.Val306Cysfs*32 (II-9 in paper)","allele":{"id":"https://genegraph.clinicalgenome.org/r/de412fdf-6647-4816-a390-e799a4843136"},"firstTestingMethod":"Sanger sequencing","phenotypes":"obo:HP_0012715","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/2f01056c-5e0a-47e8-9410-589d3ec0d2d1_variant_evidence_item"}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"three probands had severe-to-profound bilateral sensorineural hearing loss; others had mild/moderately severe bilateral sensorineural hearing loss; age of onset ranged from congenital/onset before 4 yrs. old to about 30 yrs. old","phenotypePositiveAllelePositive":6,"phenotypes":"obo:HP_0000365","proband":{"id":"https://genegraph.clinicalgenome.org/r/560b8ba8-df32-4368-aac9-d7942788bb6b"},"publishedLodScore":1.5,"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/82b784e8-7762-4234-ad64-d48bed63075f","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/82b784e8-7762-4234-ad64-d48bed63075f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/36140227","allele":{"id":"https://genegraph.clinicalgenome.org/r/ac2f1cf5-7a8b-42a9-995d-a95bc6376a3b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_177398.4(LMX1A):c.331del (p.Gln111ArgfsTer7)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573131262"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/eba145ab-9738-4e92-83f0-10ba98a070e3","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/eba145ab-9738-4e92-83f0-10ba98a070e3_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The luciferase vector system in HEK293 cells showed substantially reduced transcriptional activity for the mutants in comparison to that of the wild-type, ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/eba145ab-9738-4e92-83f0-10ba98a070e3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35711095","allele":{"id":"https://genegraph.clinicalgenome.org/r/6b812a71-7d38-4ea7-90b3-7ed7ba46c537","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_177398.4(LMX1A):c.721G>A (p.Val241Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA343476411"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d228140e-145d-45ed-b6ab-68443b9b1458","type":"EvidenceLine","dc:description":"downgraded since the variant truncates protein in exon 9/9 (not NMD-associated, removes less than 10 % (9.2 %) of protein ","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d228140e-145d-45ed-b6ab-68443b9b1458_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/38056549","allele":{"id":"https://genegraph.clinicalgenome.org/r/d45d92ee-c050-4924-b7b4-e75c15b832ff","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_177398.4(LMX1A):c.859_877del (p.Met287CysfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2837994706"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/76a60a37-52c9-4b65-a348-555f6ded7f3f","type":"EvidenceLine","dc:description":"This variant was already scored as a null mutation, so the functional evidence showing a null impact was not used as a further upgrade. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/76a60a37-52c9-4b65-a348-555f6ded7f3f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The variant truncates the protein in the last exon, and is thus not predicted to undergo NMD, but functional evidence, a luciferase factor system in HEK293 cells, showed substantially reduced transcriptional activity in comparison to that of the wild-type. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/76a60a37-52c9-4b65-a348-555f6ded7f3f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35711095","allele":{"id":"https://genegraph.clinicalgenome.org/r/f65339d8-00c7-4499-b8c9-f040585b2fce","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_177398.4(LMX1A):c.888dup (p.Gln297ThrfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3057197079"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/0236522f-1c51-4b27-9d72-b9e3837fb285","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0236522f-1c51-4b27-9d72-b9e3837fb285_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Luciferase reporter assay in HEK293T cells showed significantly reduced transcriptional activity for the p.Val241Leu mutant compared to the wild-type (PMID: 32840933).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/0236522f-1c51-4b27-9d72-b9e3837fb285_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29754270","allele":{"id":"https://genegraph.clinicalgenome.org/r/0ca4f4e8-d35e-456b-a990-041bc739783c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_177398.4(LMX1A):c.721G>C (p.Val241Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA343476410"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/70e9c56e-64f8-4c84-a745-66ffe1741d8f","type":"EvidenceLine","dc:description":"Upgraded to 1.5 pts. due to null impact of variant in functional assay ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/70e9c56e-64f8-4c84-a745-66ffe1741d8f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Showed reduced transcriptional impact comparable to null variants in luciferase reporter assay. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/70e9c56e-64f8-4c84-a745-66ffe1741d8f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35711095","allele":{"id":"https://genegraph.clinicalgenome.org/r/a1f760fb-38eb-423c-a529-95ef777d2bd1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_177398.4(LMX1A):c.719A>G (p.Gln240Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA343476415"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/bd7f50c4-07ca-4d91-bf88-18c07d2717e2","type":"EvidenceLine","dc:description":"This variant was already scored as a null mutation, so the functional evidence showing a null impact was not used as a further upgrade. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bd7f50c4-07ca-4d91-bf88-18c07d2717e2_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The luciferase factor system in HEK293 cells showed substantially reduced transcriptional activity in comparison to that of the wild-type.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/bd7f50c4-07ca-4d91-bf88-18c07d2717e2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35711095","allele":{"id":"https://genegraph.clinicalgenome.org/r/768c82b2-f176-483d-aa63-ed2692a02dce","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_177398.4(LMX1A):c.622C>T (p.Arg208Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA343476775"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/e0621dc6-c92e-4755-a640-44c933248695","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e0621dc6-c92e-4755-a640-44c933248695_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Luciferase reporter assay showed significantly reduced fold-activation of LMX1A-responsive promoter for the mutant compared to the wild-type. ","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/e0621dc6-c92e-4755-a640-44c933248695_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35254497","allele":{"id":"https://genegraph.clinicalgenome.org/r/4b7f01af-6b43-4c23-a028-4e1f22ecca05","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_177398.4(LMX1A):c.686C>A (p.Ala229Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA343476484"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8db5882c-8a31-45d9-925b-9af839cc2bd4","type":"EvidenceLine","dc:description":"Paper suggests imapct of mutation is close to a null allele, therefore, a full 1.0 pts. was added to the score. ","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8db5882c-8a31-45d9-925b-9af839cc2bd4_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Luciferase reporter assay in HEK293T cells showed significantly reduced transcriptional activity for p.Arg199Leu, compared to the wild-type. The paper suggests that the impact of the mutation is closer to a null.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/8db5882c-8a31-45d9-925b-9af839cc2bd4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32840933","allele":{"id":"https://genegraph.clinicalgenome.org/r/a7ebbf12-d994-4e04-ba3b-33423b83b341","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_177398.4(LMX1A):c.595A>G (p.Arg199Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA343476906"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/53ec2fc8-4625-4b4a-a0f9-4eb159f94f4d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/53ec2fc8-4625-4b4a-a0f9-4eb159f94f4d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Luciferase reporter assay in HEK293T cells showed significantly reduced transcriptional activity for the p.Cys97Ser mutant compared to the wild-type (PMID: 32840933)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/53ec2fc8-4625-4b4a-a0f9-4eb159f94f4d_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":11.5},{"id":"https://genegraph.clinicalgenome.org/r/163f8708-7d3b-424a-826a-76e37260745c_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/163f8708-7d3b-424a-826a-76e37260745c_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8e9289df-8794-414a-b414-6db3792ade70","type":"EvidenceLine","dc:description":"Downgrading form the default due to the fact that this was a homozygous model, while the human condition is heterozygous. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e5fcca60-1f51-4d94-9192-9dd9abff9a90","type":"Finding","dc:description":"Both the affected humans and homozygous mutant mice have deafness. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10693804","rdfs:label":"Mouse model (dreher, Jackson Laboratory)","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/63852e50-c734-4555-a60c-80d53a4e65fe","type":"EvidenceLine","dc:description":"Each of the two mutant lines is scored at 1.0 pt., as opposed to the default 2.0, due to the heterozygotes not displaying anomalies. ","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dad8665a-08c8-450e-b2f1-d99f66845317","type":"Finding","dc:description":"Both the mtl/mtl and bsd/bsd mutants have hearing loss, just like mutant humans. The heterozygous mutant mice do not exhibit abnormalities. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23226461","rdfs:label":"2 mutant lines (mtl/mtl & bsd/bsd)","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3}],"evidenceStrength":"Definitive","sequence":10295,"specifiedBy":"GeneValidityCriteria11","strengthScore":14.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/qfyS1OabFvg","type":"GeneValidityProposition","disease":"obo:MONDO_0019587","gene":"hgnc:6653","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_163f8708-7d3b-424a-826a-76e37260745c-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}